医药-话题@MedSci

#医药#

1668篇内容 | 2741人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1410027, encodeId=bda4141002e66, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=两会声音：中医药重新定义，基层机会来了, objectType=article, longId=194847, objectId=c1d619484ec5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1d619484ec5, replyNumber=0, likeNumber=51, createdTime=2020-05-29, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1d619484ec5, moduleTitle=两会声音：中医药重新定义，基层机会来了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1d619484ec5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410023, encodeId=22b1141002305, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=FDA批准Ripretinib用于四线晚期胃肠道间质瘤治疗！再鼎医药持有中国权益, objectType=article, longId=194393, objectId=2d8619439350, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d8619439350, replyNumber=0, likeNumber=60, createdTime=2020-05-20, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d8619439350, moduleTitle=FDA批准Ripretinib用于四线晚期胃肠道间质瘤治疗！再鼎医药持有中国权益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d8619439350)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410021, encodeId=ec8c141002102, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=NMPA：批准再鼎医药肿瘤电场疗法用于胶质母细胞瘤治疗上市，开创治疗新纪元, objectType=article, longId=194137, objectId=d84319413e55, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d84319413e55, replyNumber=0, likeNumber=56, createdTime=2020-05-15, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d84319413e55, moduleTitle=NMPA：批准再鼎医药肿瘤电场疗法用于胶质母细胞瘤治疗上市，开创治疗新纪元, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d84319413e55)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410022, encodeId=b1711410022d7, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=“把钱用在刀刃上”，乙类OTC等十类药品调出医保，利好医药电商, objectType=article, longId=194067, objectId=092719406eb2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=092719406eb2, replyNumber=0, likeNumber=87, createdTime=2020-05-14, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=092719406eb2, moduleTitle=“把钱用在刀刃上”，乙类OTC等十类药品调出医保，利好医药电商, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=092719406eb2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410020, encodeId=9d0f1410020c2, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=再鼎医药新型抗生素——奥玛环素上市申请获NMPA优先审评, objectType=article, longId=193902, objectId=a4ea193902d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4ea193902d3, replyNumber=0, likeNumber=106, createdTime=2020-05-12, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4ea193902d3, moduleTitle=再鼎医药新型抗生素——奥玛环素上市申请获NMPA优先审评, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4ea193902d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410019, encodeId=f3f214100198a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=半月谈聚焦中医药发展：抗疫大考之后，能否迎来机遇, objectType=article, longId=193691, objectId=952d193691e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=952d193691e2, replyNumber=0, likeNumber=54, createdTime=2020-05-09, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=952d193691e2, moduleTitle=半月谈聚焦中医药发展：抗疫大考之后，能否迎来机遇, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=952d193691e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410018, encodeId=76c2141001830, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=惠誉：新冠肺炎治疗相关定价方法可能改变医药行业经济模型, objectType=article, longId=193639, objectId=c2ae193639b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2ae193639b1, replyNumber=0, likeNumber=69, createdTime=2020-05-08, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2ae193639b1, moduleTitle=惠誉：新冠肺炎治疗相关定价方法可能改变医药行业经济模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2ae193639b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410017, encodeId=c08b141001ed3, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=FDA授予亚盛医药的第三代TKI抑制剂HQP1351孤儿药指定，用于治疗慢性粒细胞白血病, objectType=article, longId=193620, objectId=85f31936203d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85f31936203d, replyNumber=0, likeNumber=78, createdTime=2020-05-08, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85f31936203d, moduleTitle=FDA授予亚盛医药的第三代TKI抑制剂HQP1351孤儿药指定，用于治疗慢性粒细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85f31936203d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410016, encodeId=3746141001603, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=医药人注意：这些行为，重罚！, objectType=article, longId=193117, objectId=fd5619311e1a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd5619311e1a, replyNumber=0, likeNumber=0, createdTime=2020-04-30, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd5619311e1a, moduleTitle=医药人注意：这些行为，重罚！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd5619311e1a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410015, encodeId=17bc14100155f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=张伯礼：疫情一两年内不会完全止住，海外对中医药需求提高, objectType=article, longId=192922, objectId=1aaa1929229c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1aaa1929229c, replyNumber=0, likeNumber=50, createdTime=2020-04-26, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1aaa1929229c, moduleTitle=张伯礼：疫情一两年内不会完全止住，海外对中医药需求提高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1aaa1929229c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410014, encodeId=92d11410014fd, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=中老专家携手抗疫中医药写进老挝新冠肺炎诊疗方案, objectType=article, longId=192791, objectId=4056192e9127, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4056192e9127, replyNumber=0, likeNumber=66, createdTime=2020-04-24, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4056192e9127, moduleTitle=中老专家携手抗疫中医药写进老挝新冠肺炎诊疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4056192e9127)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410013, encodeId=a4b61410013b4, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=再鼎医药的PARP抑制剂Niraparib用于卵巢癌维持治疗，获得NMPA授予优先审查, objectType=article, longId=192482, objectId=1c3c1924827f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c3c1924827f, replyNumber=0, likeNumber=53, createdTime=2020-04-20, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c3c1924827f, moduleTitle=再鼎医药的PARP抑制剂Niraparib用于卵巢癌维持治疗，获得NMPA授予优先审查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c3c1924827f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410010, encodeId=533d1410010c3, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=健康时评：中医药战“疫”书写使命担当, objectType=article, longId=192219, objectId=949d192219e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=949d192219e0, replyNumber=0, likeNumber=42, createdTime=2020-04-15, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=949d192219e0, moduleTitle=健康时评：中医药战“疫”书写使命担当, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=949d192219e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410011, encodeId=26dd14100114c, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=官方发文，基层中医药人员可转正，给补助, objectType=article, longId=192217, objectId=13c919221ed3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13c919221ed3, replyNumber=0, likeNumber=51, createdTime=2020-04-15, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13c919221ed3, moduleTitle=官方发文，基层中医药人员可转正，给补助, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13c919221ed3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410012, encodeId=e8091410012e5, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=重要通知发布，影响所有医药人, objectType=article, longId=192214, objectId=1c0419221489, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c0419221489, replyNumber=0, likeNumber=75, createdTime=2020-04-15, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c0419221489, moduleTitle=重要通知发布，影响所有医药人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c0419221489)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410009, encodeId=93901410009c8, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=贩卖“统方”数据遭重罚，已成医药反腐打击重点, objectType=article, longId=192002, objectId=30b91920027f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30b91920027f, replyNumber=0, likeNumber=63, createdTime=2020-04-12, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30b91920027f, moduleTitle=贩卖“统方”数据遭重罚，已成医药反腐打击重点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30b91920027f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410007, encodeId=5190141000e68, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=黄璐琦院士：年初一带队驰援武汉，疗效就是中医药的生命力, objectType=article, longId=191883, objectId=0ed91918830b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ed91918830b, replyNumber=0, likeNumber=66, createdTime=2020-04-11, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ed91918830b, moduleTitle=黄璐琦院士：年初一带队驰援武汉，疗效就是中医药的生命力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ed91918830b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410006, encodeId=481814100063f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=再生元与再鼎医药合作开发REGN1979（CD20xCD3双特异性抗体），治疗非霍奇金淋巴瘤, objectType=article, longId=191863, objectId=981f191863d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=981f191863d9, replyNumber=0, likeNumber=65, createdTime=2020-04-11, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=981f191863d9, moduleTitle=再生元与再鼎医药合作开发REGN1979（CD20xCD3双特异性抗体），治疗非霍奇金淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=981f191863d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410005, encodeId=7c441410005a6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=亳州市政府：亳州中医药大学项目建设任务已列入规划, objectType=article, longId=191394, objectId=5cbf191394ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5cbf191394ed, replyNumber=0, likeNumber=67, createdTime=2020-04-05, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5cbf191394ed, moduleTitle=亳州市政府：亳州中医药大学项目建设任务已列入规划, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5cbf191394ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410008, encodeId=13bd14100089f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=刚刚！两个重磅医药文件公布, objectType=article, longId=191176, objectId=b6471911e6be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6471911e6be, replyNumber=0, likeNumber=53, createdTime=2020-04-02, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6471911e6be, moduleTitle=刚刚！两个重磅医药文件公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6471911e6be)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

医药

2020-05-29

cathymary (审核中...)

前往app查看评论内容

#医药#

两会声音：中医药重新定义，基层机会来了

2020-05-29

cathymary (审核中...)

前往app查看评论内容

#医药#

FDA批准Ripretinib用于四线晚期胃肠道间质瘤治疗！再鼎医药持有中国权益

2020-05-20

cathymary (审核中...)

前往app查看评论内容

#医药#

NMPA：批准再鼎医药肿瘤电场疗法用于胶质母细胞瘤治疗上市，开创治疗新纪元

2020-05-15

cathymary (审核中...)

前往app查看评论内容

#医药#

“把钱用在刀刃上”，乙类OTC等十类药品调出医保，利好医药电商

2020-05-14

cathymary (审核中...)

前往app查看评论内容

#医药#

再鼎医药新型抗生素——奥玛环素上市申请获NMPA优先审评

2020-05-12

cathymary (审核中...)

前往app查看评论内容

#医药#

半月谈聚焦中医药发展：抗疫大考之后，能否迎来机遇

2020-05-09

cathymary (审核中...)

前往app查看评论内容

#医药#

惠誉：新冠肺炎治疗相关定价方法可能改变医药行业经济模型

2020-05-08

cathymary (审核中...)

前往app查看评论内容

#医药#

FDA授予亚盛医药的第三代TKI抑制剂HQP1351孤儿药指定，用于治疗慢性粒细胞白血病

2020-05-08

cathymary (审核中...)

前往app查看评论内容

#医药#

医药人注意：这些行为，重罚！

2020-04-30

cathymary (审核中...)

前往app查看评论内容

#医药#

张伯礼：疫情一两年内不会完全止住，海外对中医药需求提高

2020-04-26

cathymary (审核中...)

前往app查看评论内容

#医药#

中老专家携手抗疫中医药写进老挝新冠肺炎诊疗方案

2020-04-24

cathymary (审核中...)

前往app查看评论内容

#医药#

再鼎医药的PARP抑制剂Niraparib用于卵巢癌维持治疗，获得NMPA授予优先审查

2020-04-20

cathymary (审核中...)

前往app查看评论内容

#医药#

健康时评：中医药战“疫”书写使命担当

2020-04-15

cathymary (审核中...)

前往app查看评论内容

#医药#

官方发文，基层中医药人员可转正，给补助

2020-04-15

cathymary (审核中...)

前往app查看评论内容

#医药#

重要通知发布，影响所有医药人

2020-04-15

cathymary (审核中...)

前往app查看评论内容

#医药#

贩卖“统方”数据遭重罚，已成医药反腐打击重点

2020-04-12

cathymary (审核中...)

前往app查看评论内容

#医药#

黄璐琦院士：年初一带队驰援武汉，疗效就是中医药的生命力

2020-04-11

cathymary (审核中...)

前往app查看评论内容

#医药#

再生元与再鼎医药合作开发REGN1979（CD20xCD3双特异性抗体），治疗非霍奇金淋巴瘤

2020-04-11

cathymary (审核中...)

前往app查看评论内容

#医药#

亳州市政府：亳州中医药大学项目建设任务已列入规划

2020-04-05

cathymary (审核中...)

前往app查看评论内容

#医药#

刚刚！两个重磅医药文件公布

2020-04-02

科室
- - 订阅+
  - 更多科室
工具
服务